1. Home
  2. RDNT vs BHVN Comparison

RDNT vs BHVN Comparison

Compare RDNT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDNT
  • BHVN
  • Stock Information
  • Founded
  • RDNT 1985
  • BHVN 2013
  • Country
  • RDNT United States
  • BHVN United States
  • Employees
  • RDNT N/A
  • BHVN N/A
  • Industry
  • RDNT Medical Specialities
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDNT Health Care
  • BHVN Health Care
  • Exchange
  • RDNT Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • RDNT 4.6B
  • BHVN 4.2B
  • IPO Year
  • RDNT 1986
  • BHVN 2017
  • Fundamental
  • Price
  • RDNT $59.47
  • BHVN $36.85
  • Analyst Decision
  • RDNT Strong Buy
  • BHVN Strong Buy
  • Analyst Count
  • RDNT 4
  • BHVN 14
  • Target Price
  • RDNT $75.50
  • BHVN $63.15
  • AVG Volume (30 Days)
  • RDNT 701.7K
  • BHVN 752.7K
  • Earning Date
  • RDNT 02-27-2025
  • BHVN 03-03-2025
  • Dividend Yield
  • RDNT N/A
  • BHVN N/A
  • EPS Growth
  • RDNT N/A
  • BHVN N/A
  • EPS
  • RDNT N/A
  • BHVN N/A
  • Revenue
  • RDNT $1,772,946,000.00
  • BHVN N/A
  • Revenue This Year
  • RDNT $14.62
  • BHVN N/A
  • Revenue Next Year
  • RDNT $8.96
  • BHVN $154.39
  • P/E Ratio
  • RDNT N/A
  • BHVN N/A
  • Revenue Growth
  • RDNT 12.20
  • BHVN N/A
  • 52 Week Low
  • RDNT $36.47
  • BHVN $26.80
  • 52 Week High
  • RDNT $93.65
  • BHVN $62.21
  • Technical
  • Relative Strength Index (RSI)
  • RDNT 35.95
  • BHVN 40.96
  • Support Level
  • RDNT $60.23
  • BHVN $38.40
  • Resistance Level
  • RDNT $64.66
  • BHVN $42.82
  • Average True Range (ATR)
  • RDNT 2.72
  • BHVN 2.14
  • MACD
  • RDNT -0.02
  • BHVN -0.16
  • Stochastic Oscillator
  • RDNT 6.04
  • BHVN 0.34

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: